Pharmaceuticals, Biotechnology and Life Sciences
LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated a second…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
– Phase 1a/1b Study of First-in-class B7-H4 Antibody as Monotherapy in Patients with Advanced Solid Tumors – SOUTH SAN FRANCISCO,…
Abstract Highlights the Effect of Dose Modification on Response to COPIKTRA in Adult Patients with CLL/SLL After At Least Two…
First Presentation of Data from EV-201 Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer Featured in…
AUSTIN, Texas–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/invivo?src=hash" target="_blank"gt;#invivolt;/agt;–First developed in 2012, Altogen’s liver-targeted in vivo transfection reagent has since been successfully used in…
Presentations include innovative cancer research, including novel CAR T technology, as well as key disease areas, including myelofibrosis and multiple…
— Methylation Technology Identifies Tumor Tissue of Origin of Multiple Cancer Types with High Accuracy — — Initial Survival Analysis…
First-Time Data from POLO Trial Evaluating LYNPARZA® (olaparib) in Germline BRCA-Mutated Metastatic Pancreatic Cancer in Plenary Session and ASCO Press…
– Phase I/II study of entrectinib, an investigational medicine, showed responses in all pediatric tumor types harboring neurotrophic tyrosine receptor…